Sight Sciences, Inc. SGHT

Updated: 10 Aug 2026

NASDAQ | Biotech | Ophthalmic medical technology

No signal published yet

We already track Sight Sciences and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Sight Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Ophthalmic medical technology
We're already tracking Sight Sciences, Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, Sight Sciences reported its second-quarter 2026 financial results, posting revenue of $23.4 million, a 20% increase year-over-year. The company raised its full-year 2026 revenue guidance to $88–$92 million, lowered its adjusted operating expense guidance, and announced expanded insurance coverage from Aetna for its OMNI and SION systems.

What Firelda Watch includes for Sight Sciences, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Sight Sciences, Inc. will be delivered in the same format.

Want to follow Sight Sciences, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Sight Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Sight Sciences, Inc. SGHT
Sight Sciences — follow and we'll monitor it
Follow Sight Sciences free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.